Temozolomid and mobility decreased Patient Reports February 08, 2012

Temozolomid Side Effects Report #5589196-6
Temozolomid side effect was reported by a Physician from GERMANY on Dec 28, 2007. Male patient, 68 years of age, weighting 147.7 lb, was diagnosed with glioblastoma and was treated with Temozolomid. After drug was administered, patient experienced the following side effects: fatigue, mobility decreased, nonspecific reaction. Temozolomid dosage: 75 MG/M2;. During the same period patient was treated with FORTECORTIN, HYDROCHLOROTHIAZIDE, UNAT, FELODIPINE, LISINOPRIL, NEXIUM. Patient was hospitalized. Patient recovered.